|
Abha Singh, MD, RhMSUS Division contact |
 |
Brief Bio
Dr. Abha Singh is Associate Professor and Division Chief of Rheumatology at the University of Arizona College of Medicine – Phoenix and Banner – University Medical Center Phoenix. She is leading the strategic growth of the division through expansion of clinical programs, interdisciplinary collaboration, research innovation, and advancement of educational initiatives.
Her research interests focus on psoriatic arthritis, precision medicine, musculoskeletal ultrasound, and ultrasound-guided synovial biopsies to better understand synovial tissue biology and identify biomarkers for personalized treatment approaches. She is focused on advancing clinical operations through innovation, incorporating artificial intelligence into rheumatology practice, and enhancing the experience of both patients and providers.
Dr. Singh specializes in the care of patients with spondyloarthritis and has established a specialized complex psoriatic disease clinic at the University of Arizona. She is RhMSUS-certified in musculoskeletal ultrasound, with expertise in diagnostic joint ultrasound for early arthritis detection and ultrasound-guided therapeutic procedures.
Dr Singh has previously served as Clinical Service Chief at the University of California, San Diego, as well as Director of the Synovial tissue research center at UCSD. She completed her internal medicine residency at the University of Iowa and rheumatology fellowship training at Mayo Clinic, Rochester.
Committed to education and mentorship, Dr. Singh works closely with fellows, residents, and medical students and has developed a comprehensive Musculoskeletal Ultrasound (MSK US) program to support rheumatology training and education.
Under Dr. Singh’s leadership, the division aims to build a nationally recognized program in inflammatory arthritis and synovial tissue research, expand precision medicine initiatives, and strengthen multidisciplinary collaborations across specialties. Her vision includes advancing innovative models of patient care, integrating emerging technologies into clinical practice, growing clinical trials and translational research programs, and developing a robust rheumatology training environment focused on excellence in patient care, education, and scientific discovery.